Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives-Reference-Cited by-同舟云学术

Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives

Published:2008-05 Issue:9 Volume:18 Page:2920-2923
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Gillespie Roger J.,Cliffe Ian A.,Dawson Claire E.,Dourish Colin T.,Gaur Suneel,Giles Paul R.,Jordan Allan M.,Knight Antony R.,Lawrence Anthony,Lerpiniere Joanne,Misra Anil,Pratt Robert M.,Todd Richard S.,Upton Rebecca,Weiss Scott M.,Williamson Douglas S.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference9 articles.

1. Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

2. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives

3. Aroylation of Fused Pyrimidines; Synthesis of 4-Aroylfuro[2,3-d]-, 4-Aroylthieno[2,3-d]-, and 4-Aroylisoxazolo[5,4-d]pyrimidines

4. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease

5. Experimental Models of Parkinson's Disease: From the Static to the Dynamic

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification;European Journal of Medicinal Chemistry;2022-07

2. Mechanochemical Rapid Synthesis of Novel Thiazoles Linked to 2H-Chromen-2-one Moiety;HETEROCYCLES;2022

3. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates;CURR DRUG TARGETS;2021

4. Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors;Journal of Medicinal Chemistry;2019-10-04

5. Computer-aided Drug Design Applied to Parkinson Targets;Current Neuropharmacology;2018-06-08